Please turn JavaScript on

IPOScoop

Click on the "Follow" button below and you'll get the latest news from IPOScoop via email, mobile or you can read them on your personal news page on this site.

You can unsubscribe anytime you want easily.

You can also choose the topics or keywords that you're interested in, so you receive only what you want.

IPOScoop title: You are being redirected...

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.64 / day

Message History

Anthropic (ANT Proposed) is on the verge of making IPO history. The San Francisco-based company, known for its Claude AI code and platform, is set to price its $61.05 billion IPO this week. The terms call for 825 million shares at a price range of $70.00 to $78.00 to raise $61.05 billion – if Anthropic’s IPO is priced at $74.00 – the mid-point of its range. But the deal could...


Read full story

vVardis Holding AG (VVVV), a Swiss dental tech start-up, upsized its IPO at pricing to 9.72 million shares – up from 8.33 million in the prospectus – and priced the deal at $18.00 – $3.00 below range – to raise $174.96 million on Thursday night, Nov. 12, 2026. vVard...


Read full story

Windward Bio (WWB), a biotech based in Basel, Switzerland, priced its IPO at $17.00 – the mid-point of its range – and sold 10.29 million shares – the number in the prospectus – to raise $174.93 million on Thursday night, Nov. 12, 2026. Windward Bio’s stock is expected...


Read full story

Anthropic (ANT Proposed), known for its Claude AI platform, launched its $61.05 billion IPO today – Tuesday, Nov. 10, 2026 – after disclosing its terms: 825 million shares at a price range of $70.00 to $78.00 a share to raise $61.05 billion, if priced at the $74.00 mid-point of its range. At pricing, Anthropic would have a market cap of $968.44 billion – just...


Read full story

Windward Bio (WWB Proposed), a Swiss biotech developing long-acting drug candidates to treat asthma, COPD and atopic dermatitis, unveiled the terms early today (Monday, Nov. 9,2026) for its $175 million IPO. Windward Bio is offering 10.29 million shares at a price range of $16.00 to $18.00 to raise $174.93 million, if priced at the $17.00 mid-point of its range, accor...


Read full story